Olema Pharmaceuticals, Inc.

NASDAQ:OLMA

Biotechnology

Healthcare
$7.06 -2.70%

-$0.26 today

Market cap
$618.50M
Beta
2.00
P/E (TTM)
-5.1
EPS (TTM)
-$1.80
52W Low $4.02High $36.26

Volume 1.18M

Average 1.27M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$178.70M

FY 2025 · Annual

Net Income

-$162.45M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development51.1M82.27M86.14M124.52M157.7M
Selling, General & Admin20.39M24.71M18.82M17.74M21M
Operating Expenses71.49M106.99M104.96M142.26M178.7M
Depreciation & Amortization163K357K377K393K490K
EBITDA(70.93M)(104.43M)(96.28M)(129.08M)(161.96M)
EBITDA Margin—————
Operating Income(71.49M)(106.99M)(104.96M)(142.26M)(178.7M)
Operating Margin—————
Interest Income442K2.23M8.32M12.68M16.22M
Interest Expense—0—00
Other Income / Expenses395K2.2M8.31M12.78M16.25M
Income Before Tax(71.1M)(104.79M)(96.66M)(129.47M)(162.45M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(71.1M)(104.79M)(96.66M)(129.47M)(162.45M)
Net Margin—————
EPS (Basic)(1.79)(2.62)(2.14)(2.20)(1.87)
EPS (Diluted)(1.79)(2.62)(2.14)(2.20)(1.87)
Weighted Avg Shares39.52M40M45.25M58.74M87.01M
Weighted Avg Shares (Diluted)39.52M40M45.25M58.74M87.01M

OLMA Earnings Waterfall · TTM

NASDAQ:OLMA · Revenue to Net Income

Key Ratios

EPS$-2.03
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-6.7
P/S Ratio0.0

Analysis

$0 of revenue converted into -$185.2M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-2.03, tying the income statement back to per-share earnings.

Competitors

Peer companies in the same sector

Health

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
10-QQuarterly reportNov 10, 2026
8-KCurrent reportNov 10, 2026
SC 13D/ASC 13D/A filingOct 16, 2026
8-KCurrent reportOct 15, 2026

How much revenue does OLMA generate?

Olema Pharmaceuticals, Inc. (OLMA) reported $0.00 of revenue in fiscal 2025.

Is OLMA profitable?

Olema Pharmaceuticals, Inc. (OLMA) reported -$162.45M of net income.